New funding will support Phase 1 studies for Spiral Therapeutics’ lead drug candidate targeting inner ear disorders and hearing loss.
{iframe}https://www.bizjournals.com/baltimore/news/2018/12/27/pharma-startup-tied-to-johns-hopkins-raises-3-7.html{/iframe}